Spravato Nasal Spray (Esketamine) – 28 mg per Device

buy spravato online, buy spravato online

Spravato nasal spray contains esketamine, an active ingredient developed for intranasal administration. Each individual Spravato nasal spray device delivers a measured 28 mg dose of esketamine. Depending on the treatment plan, healthcare professionals may administer multiple devices to provide a total dose of 56 mg or 84 mg.

The nasal spray format provides a convenient method for delivering esketamine through the nasal passages. Each device contains a controlled, measured amount of the active ingredient, helping support consistent administration during a supervised treatment session.

Spravato is designed for use as part of a structured treatment program under the guidance of a qualified healthcare professional. The appropriate total dose and treatment schedule depend on the individual’s clinical circumstances and the recommendations of their healthcare provider. The 56 mg treatment dose generally involves two 28 mg devices, while an 84 mg treatment dose generally involves three 28 mg devices.

The compact nasal spray format makes Spravato easy to handle within a professional treatment setting. Its measured-dose design provides a straightforward administration format for qualified healthcare providers and eligible patients following an established treatment plan.

Product Details

• Active ingredient: Esketamine
• Product form: Nasal spray
• Strength per device: 28 mg
• Common total doses: 56 mg or 84 mg
• Administration route: Intranasal
• Format: Measured-dose nasal spray device
• Treatment setting: Used under qualified healthcare supervision

If you are researching Spravato nasal spray or esketamine treatment, speak with a qualified healthcare professional for information about appropriate dosing, treatment suitability, and administration. Professional guidance helps ensure that the product fits the individual’s treatment plan and clinical needs.